GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Pontem Corp (NYSE:PNTM) » Definitions » Research & Development

Pontem (Pontem) Research & Development : $0.00 Mil (TTM As of Mar. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Pontem Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Pontem's Research & Development for the three months ended in Mar. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00 Mil.

Pontem Research & Development Historical Data

The historical data trend for Pontem's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pontem Research & Development Chart

Pontem Annual Data
Trend Dec20 Dec21 Dec22
Research & Development
- - -

Pontem Quarterly Data
Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pontem Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pontem  (NYSE:PNTM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Pontem Research & Development Related Terms

Thank you for viewing the detailed overview of Pontem's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Pontem (Pontem) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Pontem Corp (NYSE:PNTM) » Definitions » Research & Development
Comparable Companies
APGB LGV FVIV SCRM VYGG APSG CONX ETAC BOAC EOCW GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
2170 Buckthorne Place, Suite 320, The Woodlands, TX, USA, 77380
Website
https://www.pontemcorp.com
Pontem Corp is a blank check company.
Executives
Robert G Bohn director ONE PARK PLAZA, 11270 W. PARK PLACE, SUITE 1000, MILWAUKEE WI 53224
James Gentilcore director NINE HAMPSHIRE STREET, MANSFIELD MA 02048
Hubertus M Muhlhauser director, 10 percent owner, officer: Chairman and CEO MANITOWOC FOODSERVICE INC., 2227 WELBILT AVENUE, NEW PORT RICHEY FL 34655
Erik Olsson director C/O RSC HOLDINGS INC., 6929 E. GREENWAY PARKWAY, SCOTTSDALE AZ 85254
Luciano Mozzato director 10205 WESTHEIMER, SUITE 1000, HOUSTON TX 77042
Pontem Llc 10 percent owner 1140 AVENUE OF THE AMERICAS, 9TH FLOOR, NEW YORK NY 10036
Nina Murphy officer: Chief Financial Officer C/O PONTEM CORPORATION, 1140 AVENUE OF THE AMERICAS, 9TH FLOOR, NEW YORK NY 10036
Burak Alici director, 10 percent owner, officer: Lead Director C/O PONTEM CORPORATION, 1140 AVENUE OF THE AMERICAS, 9TH FLOOR, NEW YORK NY 10036
Peter Grosch director C/O PONTEM CORPORATION, 1140 AVENUE OF THE AMERICAS, 9TH FLOOR, NEW YORK NY 10036
Sm-invest 10 percent owner HURDNERSTRASSE 60, CH-8640 HURDEN, SCHWYZ V8 00000